New Study Reveals Connections Between Chronic Pain and Gut Microbiota

Chronic pain is a prevalent issue worldwide, affecting physical, psychological health, and economic well-being. According to recent studies, chronic pain is reported in 39% of Japanese populations and ranges from 35% to 51% in the United Kingdom. In adult Europeans, it occurs in 19% of the population, and in the United States, 20.5% of adults experience pain daily.

Potential Causes of Chronic Pain

The origins of chronic pain are complex, encompassing alterations in the nervous system, musculoskeletal deterioration, immune system disorders, physical attributes, and psychological states. Emerging research points to the gut microbiota (GM), which significantly influences these factors, potentially playing a critical role in chronic pain.

Gut Microbiota and Chronic Pain

Signaling molecules derived from the gut microbiota, such as metabolites, neurotransmitters, and neuromodulators, influence the pathogenesis of chronic pain by interacting with specific receptors and modulating both peripheral and central sensitization. These mediators play a key role in regulating primary nociceptive neuron excitability in the peripheral nervous system, contributing to peripheral sensitization. In the central nervous system, they can affect neuroinflammatory processes and central sensitization by activating blood-brain barrier cells, microglia, and infiltrating immune cells.

Study Participants and Methodology

Researchers conducted a cross-sectional survey involving 178 chronic pain patients who visited Aichi Medical University Hospital for pain management between April 2019 and June 2022. The study also included 125 healthy controls matched on age and gender. Participants’ fecal samples were collected for gut microbiota analysis.

Demographic and Medical Data

Key information assessed included age, gender, body mass index (BMI), pain intensity, pain location, psychological status, and drug use. Pain intensity and location were recorded using standardized metrics. Psychological status was evaluated using the Hospital Anxiety and Depression Scale (HADS) and the Pain Catastrophizing Scale. Data on medication use, primarily drugs used for pain management, were also collected.

Gut Microbiota Analysis

The analysis of gut microbiota composition was performed using 16S rRNA gene sequencing. The Shannon index was used to measure alpha diversity, representing the richness or diversity of bacterial genera in the sample. Beta diversity, indicated by unweighted and weighted unifrac distances, was used to compare differences in gut microbiota composition between groups.

Findings

The study revealed that chronic pain patients exhibited significantly lower gut microbiota diversity as compared to healthy controls, despite no significant differences in diversity among different pain groups. Certain bacterial families were more abundant in specific chronic pain groups:

• Patient with whole-body pain had higher levels of the Eggerthellaceae family and lower levels of Halomonas, Lachnospira.
• Patients with low back and lower extremity pain had more Fusobacterium and Sellimonas but fewer Halomonas, Romboutsia, Subdoligranulum, Faecalibacterium, ErysipelotrichaceaeUCG_003, and Ruminococcaceae.
• Headache patients showed more Actinomycetaceae, Eggerthellaceae, and fewer Romboutsia and Turicibacter.
• Participants with neck, upper back, and upper extremity pain exhibited higher Oscillibacter, Flavonifractor, Ruminococcus_torquesgroup, Clostridium_innocuum group, Eggerthella, and lower Halomonas, Romboutsia, and Coprococcus.

Impact of Gut Microbiota on Pain

The study suggests that gut microbiota plays a crucial role in chronic pain, with differences in microbial composition observed across various pain types. However, the exact mechanisms and causality between gut microbiota composition and chronic pain need further investigation.

Limitations of the Study

Several limitations were identified including:

• The study only demonstrated differences in GM composition between chronic pain patients and controls, not the impact of these changes on pain.
• Small sample sizes for each pain group.
• A higher frequency of females in all groups, potentially introducing gender bias.
• The influence of medications on gut microbiota was not fully accounted for.

Conclusion

This research highlights the potential for the gut microbiota to influence chronic pain and suggests that understanding the relationship between gut health and pain could lead to new therapeutic approaches. Future studies should explore the因果 relationship between specific gut bacteria and chronic pain types, as well as the impact of treatment-mediated changes in gut microbiota.

For more information on chronic pain and gut microbiota, stay tuned for updates on Archynetys. We will continue to bring you the latest research and insights from the medical community.

Don’t forget to like, share, and subscribe to Archynetys for more health and science news!